Miriam Latorre Millán is a project researcher for the Institute of Health Research Aragón (Miguel Servet University Hospital, Zaragoza, Spain), a teaching collaborator at the Open University of Catalonia, and a registered nutritionist. She holds two degrees, in Human Nutrition and Dietetics (2002) and in Food Science and Technology (2004), from the University of the Basque Country, a PhD in Medicine (2019), two postgraduate degrees related to R&D&I (2017) and growth and development factors (2013) from the University of Zaragoza, and three other postgraduate degrees related to alternative therapies from the Spanish Distance Learning University (UNED, 2011-2012). She has more than 30 articles, 60 congress communications, and 25 research projects to her name, including competitive and excellence ones, most related to COVID-19 and influenza surveillance and vaccine effectiveness, but also to children's nutrition. She has been working as a researcher for more than 15 years at several hospitals and universities. She is a member of the Research Group on Infections Difficult to Diagnose and Treat, and the Paediatric Nutrition Specialisation Group of the Spanish Academy of Nutrition and Dietetics. She has received several prizes and grants from different entities, including the Aragonese Society of Healthcare Quality, the Spanish Federation of Nutrition, Food and Dietetics, the Spanish Society of Paediatric Endocrinology, and the Federation of European Microbiological Societies.
Ana María Milagro Beamonte is a specialist physician leading the Molecular Biology Area at the Microbiology and Parasitology Department, Miguel Servet University Hospital (Zaragoza, Spain), as well as being quality coordinator and supervisor. She obtained a degree in Medicine and Surgery in 1989, specialised in Microbiology and Parasitology in 2000, and reached research proficiency in 1995 (all at the University of Zaragoza), followed by a Master's in Infectious Diseases in Intensive Care in 2019 (at the University of Valencia). She is an expert in virology, microbiology, and molecular biology. She has more than 35 articles, 100 congress communications, and 30 biomedical research projects to her name, being principal investigator in more than a half, most of them related to COVID-19 or influenza, vaccine effectiveness, genetic characterization (including sequencing), and evaluation of molecular biology assays. These projects have been both competitive and non-competitive, national and international, including excellence projects (H2020). She is also a current reviewer of an indexed journal, and supervises end-of-degree and master’s projects. She is a member of the Research Group on Infections Difficult to Diagnose and Treat, the Spanish Society of Microbiology, the SiVIRA group (Acute Respiratory Infection Surveillance System), and the Spanish Influenza and SARI sentinel network, part of the National Epidemiological Surveillance Network of the Carlos III Health Institute.
the VEBIS HCW VE Study Group